Skye Bioscience SKYE
NASDAQ SKYE
$1.61 +0.01 (+0.95%)
As of: Sep 30, 2026 · 9:38 AM EDT

Skye Bioscience (SKYE) Total Liabilities (2012 - 2026)

Updated

Skye Bioscience (SKYE) recorded Total Liabilities of $11.53 million in Q2 2026, up 35.9% from $8.48 million a year earlier and up 10.8% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Total Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Skye Bioscience reported Total Liabilities of $8.29 million, up 79.7% from FY2024.

  • Annual Total Liabilities has a five-year compound annual growth rate of 30.1% (FY2020 to FY2025).
  • Across earlier years, Total Liabilities came in at $4.61 million in FY2024 (-67.2%), $14.07 million in FY2023 (+16.1%), $12.12 million in FY2022 (+203.7%) and $3.99 million in FY2021 (+79.7%).
  • The Q2 2026 figure is the highest quarterly Total Liabilities since Q2 2024.
  • On a year-over-year basis, Total Liabilities has increased for four consecutive quarters, with growth averaging 2.4% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 203.7% in Q4 2022, against a decline of 67.2% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $10.4 million (Q1 2026), $8.29 million (Q4 2025) and $8.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Skye Bioscience 7.07 Mn 7.07 Mn - 11.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.53 Mn
Mar 31, 2026 10.40 Mn
Dec 31, 2025 8.29 Mn
Sep 30, 2025 8.49 Mn
Jun 30, 2025 8.48 Mn
Mar 31, 2025 5.54 Mn
Dec 31, 2024 4.61 Mn
Sep 30, 2024 5.73 Mn
Jun 30, 2024 14.45 Mn
Mar 31, 2024 15.95 Mn
Dec 31, 2023 14.07 Mn
Sep 30, 2023 13.91 Mn
Jun 30, 2023 10.03 Mn
Mar 31, 2023 9.37 Mn
Dec 31, 2022 12.12 Mn
Sep 30, 2022 6.15 Mn
Jun 30, 2022 5.27 Mn
Mar 31, 2022 4.24 Mn
Dec 31, 2021 3.99 Mn
Sep 30, 2021 3.42 Mn
API Access

Skye Bioscience Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=SKYE&period=max&api_key=YOUR_API_KEY